Hiroshi Iwai

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Omalizumab is effective for a patient with pollen-food allergy syndrome who experienced intractable lip edema”.

Omalizumab is effective for a patient with pollen-food allergy syndrome who experienced intractable lip edema

Auris Nasus Larynx(2023)10.1016/j.anl.2022.12.001

N/A

0.556DataRank · unranked

10 citations

Satoko Hamada, Yoshiki Kobayashi, Masami Shimono, Akihiro Shimamura, Akira Kanda +3 more

Inoculation of lymphocytes from young mice prevents progression of age-related hearing loss in a senescence-associated mouse model

Experimental Gerontology(2023)10.1016/j.exger.2023.112184

N/A

0DataRank · unranked

7 citations

Hiroshi Iwai, Muneo Inaba, Dan Van Bui, Toru Miwa, Linh Manh Nguyen +8 more